Sarah Ketterer's portfolio
In the Q2 2026 13F, filed August 13, 2026, Causeway Capital Management reported 122 US stock positions worth $9.2B. The largest was AstraZeneca (AZN) at 19.0% of the portfolio. New positions: NetEase (NTES), Boston Scientific (BSX) and JD.com Inc Adr (JD). Added to: AstraZeneca (AZN) and Carnival (CCL). The Q3 2026 13F is due by November 14, 2026.
What changed in Q2 2026
Compared with the previous 13F. Values are as reported at quarter end. How to read a 13F.
New positions
- NetEaseNTES$73M
- Boston ScientificBSX$31M
- JD.com Inc AdrJD$31M
- H World GroupHTHT$24M
- OceanaGoldOGC$23M
- Arcos DoradosARCO$16M
- Toronto Dominion BankTD$12M
- Canadian Imperial Bank Of CommerceCM$10M
- Suncor EnergySU$7M
- iShares MSCI Emerging Markets ETFEEM$5M
Added to
- AstraZenecaAZN$1.8B
- CarnivalCCL$1.2B
- Taiwan Semiconductor ManufacturingTSM$254M
- Alaska AirALK$166M
- Carrier GlobalCARR$160M
- Merck & CompanyMRK$123M
- Meta PlatformsMETA$113M
- CredicorpBAP$100M
- SAPSAP$97M
- Everest GroupEG$90M
Trimmed
- Smurfit WestRockSW$696M
- Canadian Pacific Kansas CityCP$582M
- AlphabetGOOG$112M
- BarclaysBCS$107M
- Alibaba Group HoldingBABA$96M
- Zimmer BiometZBH$68M
- BoeingBA$68M
- CitigroupC$64M
- BiogenBIIB$60M
- Analog DevicesADI$56M
Sold out
None this quarter.
Holdings
122 US-listed positions in the Q2 2026 13F, largest first (top 50 shown; all of them in Investingly).
| Stock | % of portfolio | Value | Shares | Last quarter |
|---|---|---|---|---|
| AstraZenecaAZN | 18.97% | $1.8B | 9,357,390 | Added |
| CarnivalCCL | 12.74% | $1.2B | 41,190,606 | Added |
| Deutsche Bank Ag | 10.77% | $994M | 29,358,318 | Held |
| Smurfit WestRockSW | 7.53% | $696M | 15,039,041 | Trimmed |
| Canadian Pacific Kansas CityCP | 6.30% | $582M | 6,711,483 | Trimmed |
| Taiwan Semiconductor ManufacturingTSM | 2.75% | $254M | 532,052 | Added |
| Alaska AirALK | 1.80% | $166M | 3,183,163 | Added |
| Carrier GlobalCARR | 1.73% | $160M | 2,178,506 | Added |
| Live Nation Entertainment | 1.40% | $129M | 706,301 | Held |
| Merck & CompanyMRK | 1.33% | $123M | 954,932 | Added |
| Meta PlatformsMETA | 1.23% | $113M | 201,459 | Added |
| AlphabetGOOG | 1.21% | $112M | 316,217 | Trimmed |
| BarclaysBCS | 1.16% | $107M | 3,975,718 | Trimmed |
| CredicorpBAP | 1.08% | $100M | 255,436 | Added |
| SAPSAP | 1.05% | $97M | 629,801 | Added |
| Alibaba Group HoldingBABA | 1.03% | $96M | 995,040 | Trimmed |
| Axis Capital Holdings | 1.00% | $92M | 859,727 | Held |
| Everest GroupEG | 0.98% | $90M | 252,702 | Added |
| Ingersoll RandIR | 0.92% | $85M | 1,033,693 | Added |
| Koninklijke PhilipsPHG | 0.90% | $83M | 3,061,962 | Added |
| Novo Nordisk A/SNVO | 0.87% | $80M | 1,677,615 | Added |
| Jones Lang LaSalleJLL | 0.83% | $77M | 248,252 | Added |
| Citizens FinancialCFG | 0.82% | $75M | 1,077,093 | Added |
| NetEaseNTES | 0.79% | $73M | 572,412 | New |
| DiageoDEO | 0.78% | $72M | 899,015 | Added |
| Zimmer BiometZBH | 0.73% | $68M | 788,810 | Trimmed |
| BoeingBA | 0.73% | $68M | 313,048 | Trimmed |
| CitigroupC | 0.69% | $64M | 458,858 | Trimmed |
| Natwest GroupNWG | 0.67% | $61M | 3,487,290 | Added |
| BiogenBIIB | 0.65% | $60M | 278,283 | Trimmed |
| Gold FieldsGFI | 0.62% | $58M | 1,713,233 | Added |
| Analog DevicesADI | 0.61% | $56M | 142,050 | Trimmed |
| RelxRELX | 0.60% | $56M | 1,762,329 | Trimmed |
| AngloGold AshantiAU | 0.60% | $56M | 688,027 | Trimmed |
| Ing Groep Nv | 0.57% | $53M | 1,690,687 | Held |
| Booz Allen Hamilton HoldingBAH | 0.56% | $52M | 849,966 | Trimmed |
| Texas InstrumentsTXN | 0.54% | $50M | 166,496 | Trimmed |
| National GridNGG | 0.53% | $49M | 590,240 | Added |
| DTE EnergyDTE | 0.53% | $49M | 320,526 | Trimmed |
| PfizerPFE | 0.50% | $46M | 1,916,801 | Added |
| Petroleo Brasileiro Sa - Petrobras | 0.49% | $45M | 3,096,624 | Held |
| PrudentialPUK | 0.49% | $45M | 1,689,218 | Added |
| Smith & Nephew SNATSSNN | 0.49% | $45M | 1,565,167 | Added |
| TAL Education GroupTAL | 0.43% | $39M | 4,125,430 | Added |
| iShares MSCI India Small-Cap ETFSMIN | 0.42% | $38M | 542,849 | Added |
| UnitedHealth GroupUNH | 0.39% | $36M | 87,447 | Added |
| Walt Disney Co/The | 0.38% | $35M | 360,600 | Held |
| SanofiSNY | 0.37% | $34M | 804,056 | Trimmed |
| British American Tobacco p.l.c.BTI | 0.37% | $34M | 547,925 | Added |
| Sumitomo Mitsui Financial | 0.36% | $33M | 1,392,610 | Held |
By sector
Share of the reported value.
Reported value over time
Total 13F value at each quarter end.
Questions
What stocks does Sarah Ketterer own?
In the Q2 2026 13F, Causeway Capital Management reported 122 US stock positions worth $9.2B. The largest: AstraZeneca (AZN) 19.0%, Carnival (CCL) 12.7%, Deutsche Bank Ag 10.8%, Smurfit WestRock (SW) 7.5%, Canadian Pacific Kansas City (CP) 6.3%.
What did Sarah Ketterer buy last quarter?
In Q2 2026: new position in NetEase (NTES); new position in Boston Scientific (BSX); new position in JD.com Inc Adr (JD); added to AstraZeneca (AZN); added to Carnival (CCL); added to Taiwan Semiconductor Manufacturing (TSM).
What did Sarah Ketterer sell last quarter?
In Q2 2026: cut Smurfit WestRock (SW); cut Canadian Pacific Kansas City (CP); cut Alphabet (GOOG).
When is Sarah Ketterer's next 13F?
13F filings are due 45 days after each quarter ends. The Q3 2026 filing is due by November 14, 2026.
More investors
13F filings list US-listed long positions (and some options) held at quarter end. They leave out short positions, cash, bonds and non-US holdings, and arrive up to 45 days after the quarter ends, so the investor may have traded since. Information only, not investment advice.